Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Kineret Market Size And Revenue Forecast Through 2030
The expansion observed during the historical timeframe was driven by several key elements: the considerable demand for treatments addressing inflammatory conditions, the proven effectiveness of interleukin-1 inhibition, more accurate identification of rare syndromes through enhanced diagnostics, the integration of biologic therapies within hospital settings, and the presence of extensive long-term safety data.
The expansion projected for the forecast period is driven by heightened awareness of autoinflammatory conditions, entry into novel therapeutic applications, greater utilization of biologics in children, enhanced availability of specialized medical services, and continuous advancements in biologic development. Key developments shaping this period consist of broader adoption of IL-1 inhibitors, increased management of autoinflammatory disorders, progress in pediatric inflammatory treatment, a shift toward precisely targeted cytokine-based therapies, and growing application in uncommon inflammatory syndromes.
Download A Free Sample Report For Comprehensive Market Insights:
Kineret Market Growth Drivers: What Factors Are Accelerating Expansion?
The expected expansion of the kineret market is being driven by the growing incidence of autoimmune diseases. Autoimmune diseases are a category of disorders in which the immune system erroneously attacks the body’s own cells, tissues, and organs, perceiving them as external threats. This rise in autoimmune conditions is linked to a mix of genetic, environmental, and lifestyle influences. Kineret is a drug that can aid in treating autoimmune diseases, especially for controlling conditions marked by excessive inflammation when the immune system assaults the body’s tissues. As an example, in May 2023, a study of 22 million people by the National Institute for Health and Care Research (NIHR), a UK-based health research organization, showed that autoimmune disorders now affect about one in ten people, with 19 such diseases impacting roughly 10% of the population, 13% of women, and 7% of men. Consequently, the increasing frequency of autoimmune diseases is fueling growth in the kineret market.
Kineret Market Driver: Rising Prevalence Of Inflammatory Diseases Driving Growth In The Market
The kineret market is anticipated to be propelled forward by the increasing occurrence of inflammatory diseases. Inflammatory diseases are conditions where the immune system reacts abnormally, resulting in chronic or acute inflammation within tissues or organs. This uptick in inflammatory diseases stems from factors like an aging population, greater exposure to environmental pollutants, and lifestyle choices such as poor nutrition, inactivity, and smoking. Kineret (anakinra) works to control inflammatory diseases by blocking interleukin-1 (IL-1), a key protein that fuels inflammation. For instance, in 2023, Crohn’s and Colitis Canada, a nonprofit organization based in Canada, reported that the number of Canadians with IBD is growing quickly, from 322,600 in 2023 (0.8% of the population) to 470,000 by 2035 (1.1% of the population). In 2023, 11,000 people will be diagnosed (one every 48 minutes), and by 2035, this figure will climb to 14,000 (one every 38 minutes). Thus, the rising prevalence of inflammatory diseases is stimulating growth in the kineret market.
Kineret Market Segmentation And Category Breakdown
The kineret market covered in this report is segmented –
1) By Indication: Treatment Of Rheumatoid Arthritis, Treatment Of Still’s Disease, Treatment Of Cryopyrin-Associated Periodic Syndromes, Treatment Of Neonatal-Onset Multisystem Inflammatory Disease (NOMIDN)
2) By Formulation: Injectable formulation, Pre-filled Syringes Or Auto-injectors
3) By Patient Demographics: Pediatric Patients, Adult Patients, Geriatric Patients
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Wholesalers And Distributors
5) By End-User: Hospitals, Specialty Clinics, Outpatient Treatment Centers, Home Healthcare Providers
Kineret Market Trends: What Is Shaping Future Industry Growth?
A major trend currently shaping the Kineret market involves the strategic collaborations companies are pursuing to create innovative Kineret-based products and secure a competitive edge. Through these alliances, market participants are able to combine resources and expertise, enhance research and development activities, increase their market footprint, and speed up product commercialization—ultimately driving innovation and sector growth. As a concrete example, in May 2024, Swedish Orphan Biovitrum AB, a biopharmaceutical company headquartered in Sweden, established a partnership with Handok Inc., a pharmaceutical firm based in South Korea, to bring Kineret (anakinra) to the South Korean market. This joint effort integrates Handok’s in-depth knowledge of the local market with Sobi’s global biopharmaceutical proficiency, particularly in the area of rare diseases.
Kineret Market Competitive Analysis Of Major Industry Participants
Major companies operating in the kineret market are Sobi (Swedish Orphan Biovitrum AB)
Access The Complete Kineret Market Report:
Kineret Market Regional Outlook: Where Are The Largest Opportunities Located?
North America was the largest region in the kineret market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kineret market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model